Ponta Grossa (PR) approves the use of inactive drugs

The municipality of Ponta Grossa (PR) in the second round approved a bill allowing the distribution of drugs for early treatment of covid-19 in SUS (Unified Health System), even without scientific evidence of the effectiveness of the so-called “covid kit”. Today noon, the bill has been approved by 11 parliamentarians, five of whom are against it and abstained from voting Now, the bill will be approved by the executive branch.

By approving this measure, the measure authorizes the municipality of Ponta Grossa to provide a set of medicines for early treatment of the disease free of charge. Corona Virus. Among the treatments are hydroxychloroquine, ivermectin and azithromycin, which are used for different types of parasite infestations.

The World Health Organization (WHO) has already used its veto power against The use of ivermectin in the treatment of Covid-19And they reaffirmed that There is no scientific evidence that chloroquine is effective.

One of the authors of the project, consultant Leandro Bianco (Republicans), defends that it is another option for the patient to confront Covid-19. The idea is to create an immediate care center, where patients are treated by a SUS doctor who will be free to prescribe treatment early or not. “We want a partnership with the private sector,” says a councilor. “Public funds will not be used.”

The draft law stipulates that medicines will only be distributed by prescription. The city council is waiting for the project to be redirected for analysis. The Paraná State Health Minister has yet to comment on the project.

The disputing parties undertake to go to court

If the bill is approved by Mayor Elizabeth Schmidt, PT and the PCdoB promise to file Adin (Direct Action for Unconstitutionality) in the state court of justice.

According to Labor Mayor Nelson Nevis, the approval is of no benefit. “We understand that some are trying to stick to miracle formulas at such a difficult time and with so many deaths, but we are convinced that the” Covid toolkit “does not bring any benefit and may exacerbate the condition of people infected with the new Coronavirus,” says Neves.

Treatment is not recommended

Since the start of the epidemic, early treatment of coronavirus has been controversial. The protocol was rejected by the Brazilian health authorities and the World Health Organization due to the lack of scientific evidence against the disease.

Last week, a suspected death due to early treatment had major ramifications in Paraná. Vice President of the Trade Association of Paraná, Luiz Antonio Liberevost, died months after being infected with the Corona virus. It is suspected that the death may be related to ineffective Covid-19 drugs.

His son, Counselor Alexander Librevost, says his father was a proponent of so-called “early treatment”. “There were four relapses of coma and five months of struggle,” he says.

Watch how each board member voted for the COVID-19 Early Treatment Project:

Favor